ArticleAge and ageing2026
Exploring cost trajectories of patients admitted to geriatric rehabilitation in the Netherlands.
Article in Age and ageing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveGeriatric rehabilitation (GR) is an essential component of transitional care. However, insight into longitudinal care use and related costs is limited. This study mapped GR trajectories over a six-month period, identified latent groups with similar cost patterns and examined patient-level cost drivers.
methodWe analysed administrative claims data from Statistics Netherlands, focusing on total trajectory costs for GR patients admitted between 1 February and 31 July 2022. Costs included hospital care (inpatient and outpatient), district nursing, long-term care (at home and in nursing homes) and short-term residential care. We used descriptive statistics, group-based trajectory modelling and logistic regression to examine differences between the identified cost groups.
resultsOver six months, 27 462 patients received GR, with a mean total cost of €40 469 (SD = €23 033). Sixty-eight percent of patients returned home, of whom 17% received home-based GR. Two latent groups were identified: a lower-cost group (88%) with mean costs of €35 024 (SD = 16 408), and a higher-cost group (12%) with mean costs of €82 012 (SD = 23 928). Patient characteristics only partially explained group membership. The higher-cost group accounted for 23% of total costs, mainly due to hospital (re)admissions, nursing home admissions and longer GR stays.
conclusionGR costs were unevenly distributed: 12% of patients incurred 23% of total costs. Key factors associated with high costs were hospital care, nursing home admissions and prolonged GR stays. Early identification and better care coordination, including shifting care closer to home, may improve continuity, reduce costs and support more efficient geriatric rehabilitation delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.